Copyright
©2012 Baishideng Publishing Group Co.
World J Hepatol. Dec 27, 2012; 4(12): 382-388
Published online Dec 27, 2012. doi: 10.4254/wjh.v4.i12.382
Published online Dec 27, 2012. doi: 10.4254/wjh.v4.i12.382
Table 1 Criteria used for histological scoring[21]
Steatosis: |
0 : None |
1: up to 33% |
2: 33%-66% |
3: > 66% |
Hepatocyte ballooning |
0: None |
1: Occasional, Zone 3 |
2: “Obvious” Zone 3 |
3: Marked, predominantly Zone 3 |
Mallory bodies |
0: No Mallory bodies |
1: Fewer than two in 10 to 20 × fields |
2: More than two in 10 to 20 × fields |
Glycogenated nuclei |
0: Absent |
1: Occasional |
2: Several |
Lobular inflammation (inflammatory foci per 20 × with a 20 × ocular) |
0: None |
1: 1 to 2/20 |
2: Up to 4/20 |
3: More than 4/20 |
Portal inflammation |
0: None |
1: Mild |
2: Moderate |
3: Severe |
Fibrosis score: |
Stage 0: No fibrosis |
Stage 1: Zone 3 perisinusoidal/pericellular fibrosis; focally or extensively present |
Stage 2: Zone 3 perisinusoidal/pericellular fibrosis with focal or extensive periportal fibrosis |
Stage 3: Zone 3 perisinusoidal/pericellular fibrosis and portal fibrosis with a focal or extensive bridging fibrosis |
Stage 4: Cirrhosis |
- Citation: Vargas V, Allende H, Lecube A, Salcedo MT, Baena-Fustegueras JA, Fort JM, Rivero J, Ferrer R, Catalán R, Pardina E, Ramón y Cajal S, Guardia J, Peinado-Onsurbe J. Surgically induced weight loss by gastric bypass improves non alcoholic fatty liver disease in morbid obese patients. World J Hepatol 2012; 4(12): 382-388
- URL: https://www.wjgnet.com/1948-5182/full/v4/i12/382.htm
- DOI: https://dx.doi.org/10.4254/wjh.v4.i12.382